The Venetian hotel in Las Vegas, site of the upcoming 2019 ISPA Conference & Expo, has agreed to allow exhibitors of CBD products at the annual trade show, reversing a stand set earlier this year.
CBD, or cannabidiol oil, is an active yet non-psychoactive ingredient derived from the marijuana plant, and is believed to treat a host of issues, from stress and anxiety to inflammation, joint pain and muscle soreness. The oil is increasingly being used in spa products
CBD products with less than 0.3% THC will now be allowed on property at The Venetian for the ISPA Conference & Expo, but must be in full compliance with the US’s FDA requirements.
Additionally, exhibitors displaying such products on the floor must produce Certificates of Analysis issued by an independent lab identifying that the THC levels in the CBD products on display are less than 0.3%, as well as information regarding the independent lab that conducted such testing, including license and certification information for the lab that performed the analysis, license/certification numbers for that lab, and the name and contact information of the agency that issued the license and certification.
“We have been working tirelessly to educate and negotiate with (The Venetian) to lift this restriction that so greatly impacts our members and our industry,” said Garrett Mersberger, ISPA chair, in an email to members. “Thanks again for your unwavering support of ISPA – whether at Conference or throughout the year, ISPA is there to help fight for our industry.”
The ISPA Conference & Expo
takes place next week, from the 11-13 September.